Cell Therapy News/Articles, page-11586

It significantly reduces risk of covid ARDS.

It would be ignorant to not think that widespread vaccine rollout would affect how large the market is. Sure, one vaccinated person doesn't equal one person who won't get ARDS, but it's pretty close.

I'm saying focus on heart failure. Why is everyone ignoring heart failure here and going on about covid ARDS?

Even though that's the indication with a falling market?

Even though it's the indication that was just slapped together because covid came around?

Even though the trials were stopped for futility (doesn't mean it doesn't work, means they'll need another trial).

Even though it's a very saturated market?

Because it's sexier than heart failure. The hype is there. It's what's on everyone's minds.

Don't get distracted by hype and lose sight of everything else.

To the point where you update the group daily on "deaths from covid, uh oh", almost like you're celebrating, you ignore the promising data of other effective covid medication regimens and push antivax sentiment (some members here).

Heart failure, that's where the money is. Tell me why you think it isn't?